MedPath

SARS-COV-2 and COVID-19 - A Randomized controlled trail (unblinded)

Phase 2
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/08/027033
Lead Sponsor
Government siddha medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Rt-PCR positive patients, Asymptomatic patients, Fever, Dry cough, Sore throat, Difficulty in breathing

Exclusion Criteria

Bronchogeniccarcinoma, Pulmonary TB, Pregnancy and lactating mothers, Status asthmatics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcomes is mainly assessed by reduction in Clinical symptoms and Rt-PCR test NegativeTimepoint: 3 Months
Secondary Outcome Measures
NameTimeMethod
Outcomes is mainly assessed by reduction in Clinical symptoms and Rt-PCR test Negative <br/ ><br>The outcome is assessed by patients recovery progress with faster reductions in clinical symptoms and Rt-PCR test negative,also to avoid the mortality rate by administering Allopathy and Siddha medicines for the easy recovery and saftety measures in the treatment for SARS-CoV-2 and COVID-19.Timepoint: 3 Months
© Copyright 2025. All Rights Reserved by MedPath